Evidence map›Paper›PMID 35549334›Full record

ArticleJournal of chemical theory and computation2022

Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition.

Carlos A Ramos-Guzmán, José Luis Velázquez-Libera, J Javier Ruiz-Pernía, Iñaki Tuñón

Open access · hybridAbstract read
In one paragraph

Article in Journal of chemical theory and computation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. CHARMM-GUIJournal of chemical theory and computation · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Carlos A Ramos-GuzmánDepartamento de Química Física, Universitat de Valencia, Burjassot, Valencia 46100, Spain.
José Luis Velázquez-LiberaDepartamento de Química Física, Universitat de Valencia, Burjassot, Valencia 46100, Spain.ORCID 0000-0002-4941-6619
J Javier Ruiz-PerníaDepartamento de Química Física, Universitat de Valencia, Burjassot, Valencia 46100, Spain.ORCID 0000-0002-4640-0419
Iñaki TuñónDepartamento de Química Física, Universitat de Valencia, Burjassot, Valencia 46100, Spain.ORCID 0000-0002-6995-1838
Universitat de València · ESUniversity of Talca · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cysteine proteases are an important target for the development of inhibitors that could be used as drugs to regulate the activity of these kinds of enzymes involved in many diseases, including COVID-19. For this reason, it is important to have methodological tools that allow a detailed study of their activity and inhibition, combining computational efficiency and accuracy. We here explore the performance of different quantum mechanics/molecular mechanics methods to explore the inhibition reaction mechanism of the SARS-CoV-2 3CL protease with a hydroxymethyl ketone derivative. We selected two density functional theory (DFT) functionals (B3LYP and M06-2X), two semiempirical Hamiltonians (AM1d and PM6), and two tight-binding DFT methods (DFTB3 and GFN2-xTB) to explore the free energy landscape associated with this reaction. We show that it is possible to obtain an accurate description combining molecular dynamics simulations performed using tight-binding DFT methods and single-point energy corrections at a higher QM description. The use of a computational strategy that provides reliable results at a reasonable computational cost could assist the in silico screening of possible candidates during the design of new drugs directed against cysteine proteases.

Indexed as

COVID-19Cysteine ProteasesCoronavirus 3C ProteasesCysteine EndopeptidasesHumansMolecular Docking SimulationPeptide HydrolasesProtease InhibitorsSARS-CoV-2Viral Nonstructural ProteinsCoronavirus 3C ProteasesCysteine EndopeptidasesCysteine ProteasesPeptide HydrolasesProtease InhibitorsViral Nonstructural Proteins

Identifiers

PMID35549334
PMCPMC9115880
OpenAlexW4280544645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.